|
|
|
|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | C12P 21/02 | (2006.01) |
| C12N 5/00 | (2006.01) | ||
| C12P 21/00 | (2006.01) | ||
| C07K 16/00 | (2006.01) |
| (11) | Number of the document | 2726600 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12738674.6 |
| Date of filing the European patent application | 2012-06-29 | |
| (97) | Date of publication of the European application | 2014-05-07 |
| (45) | Date of publication and mention of the grant of the patent | 2017-02-15 |
| (46) | Date of publication of the claims translation | 2017-05-25 |
| (86) | Number | PCT/US2012/045070 |
| Date | 2012-06-29 |
| (87) | Number | WO 2013/006479 |
| Date | 2013-01-10 |
| (30) | Number | Date | Country code |
| 201161503737 P | 2011-07-01 | US |
| (72) |
FOLLSTAD, Brian, D., US
MCCOY, Rebecca, E., US
MORRIS, Arvia, E., US
|
| (73) |
Amgen Inc.,
One Amgen Center Drive, Thousand Oaks, California 91320,
US
|
| (74) |
Genė Ona SRUOGIENĖ,
UAB TARPINĖ, A.P.Kavoliuko g. 24-152, LT-04328 Vilnius,
LT
|
| (54) | Žinduolių ląstelių kultūra |
| MAMMALIAN CELL CULTURE |
| Payment date | Validity (years) | Amount | |
| 2023-05-23 | 12 | 289.00 EUR |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2022-10-06 |